<DOC>
	<DOC>NCT02307656</DOC>
	<brief_summary>The primary objective is to assess the taste properties of atazanavir (ATV) and cobicistat (COBI) alone and in combination as well as oral test formulations containing both ATV and COBI.</brief_summary>
	<brief_title>Taste Properties of Atazanavir and Cobicistat</brief_title>
	<detailed_description />
	<mesh_term>Cobicistat</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Men and women, ages ≥18 years Subjects who are qualified professional sensory panelists Healthy subjects as determined by no clinically significant deviation from normal in medical history and physical assessment Any acute or chronic condition that may alter taste or smell sensory perception Any significant acute or chronic medical illness or any surgery within 4 weeks of the study drug administration Positive HIV test using an oral swab kit (such as OraQuick®) to detect HIV1 or 2 antibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>